Medical Laboratories & Research More
- 201-500 Employees
- Based in Portsmouth, New Hampshire
Novocure is an oncology company developing a profoundly different cancer treatment centered on a proprietary therapy called TTFields, the use of electric fields tuned to specific frequencies to disrupt solid tumor cancer cell division. Novocure’s commercialized product, Optune, is approved for the treatment of adult patients with glioblastoma.
Most Recent Responsibility Report
2022 Environmental, Social & Governance Report
NovoCure Limited does not currently have any hardcopy reports on ResponsibilityReports.com. Click the button below to request a report when hardcopies become available.
Please fill out the form below and click "Place Order" to complete your order.
Archived Responsibility Reports
Our service enables potential investors to review the most recent and archived NovoCure Limited Sustainability Report, NovoCure Limited Corporate Social Responsibility Report, NovoCure Limited CSR Report, NovoCure Limited Corporate Responsibility, NovoCure Limited CR Report, NovoCure Limited Citizenship Report, NovoCure Limited ESG Report, and NovoCure Limited Environmental Report online.